Drug pricing will continue to remain a major challenge for the pharmaceutical industry. It was scored as the number one impediment to industry growth when healthcare professionals were asked to rate the most negative emerging regulatory and macroeconomic trends for the 2 019, 2020, 2021 and 2022 industry outlook, states Global data, a data and analytics company., Drug pricing will continue to remain a major challenge for the pharmaceutical industry. It was scored as the number one impediment to industry growth when healthcare professionals were asked to rate the most negative emerging regulatory and macroeconomic trends for the 2 019, 2020, 2021 and 2022 industry outlook, states Global data, a data and analytics company., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way